Back
Sands China Vs. Spyre Therapeutics Industry Stock Comparison
Sell
21
SCHYY
Sands China
Last Price:
20.95
Seasonality Move:
0.75%
Sell
28
SYRE
Spyre Therapeutics
Last Price:
22.71
Seasonality Move:
49.76%
Sell
21
Sands China (SCHYY)
is a Sell
Is Sands China a Buy, Sell or Hold?
- The current Sands China [SCHYY] share price is $21.44. The Score for SCHYY is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- SCHYY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $23.39. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCHYY Stock Price Chart
What is Sands China's stock price today?
-
The Sands China share price today is $21.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCHYY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight buying pressure.
SCHYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.87 | Sell |
| Relative Strength Index (14 RSI): | 23.8 | Sell |
| Chaikin Money Flow: | 25621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.33 - 24.79) | Sell |
| Bollinger Bands (100): | (23.89 - 28.73) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.1 | Sell |
| Relative Strength Index (14 RSI): | 29.8 | Sell |
| Chaikin Money Flow: | 200039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.91 - 36.47) | Sell |
| Bollinger Bands (100): | (27.05 - 39.23) | Sell |
SCHYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.26 | Sell |
| 20-day SMA: | 23.1 | Sell |
| 50-day SMA: | 24.26 | Sell |
| 200-day SMA: | 27.25 | Sell |
| 8-day EMA: | 22.22 | Sell |
| 20-day EMA: | 23.06 | Sell |
| 50-day EMA: | 24.37 | Sell |
| 200-day EMA: | 27.28 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.36 | Sell |
| 20-day SMA: | 31.09 | Sell |
| 50-day SMA: | 33.45 | Sell |
| 200-day SMA: | 24.51 | Sell |
| 8-day EMA: | 25.8 | Sell |
| 20-day EMA: | 29.51 | Sell |
| 50-day EMA: | 32.17 | Sell |
| 200-day EMA: | 27.01 | Sell |
Sands China Earnings Growth & SCHYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Sands China Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||